Traffic Roots Audience Pixel
Protectx

A safer future isn’t just something we wish for.

We’re creating it.

OUR MISSION:
TO DELIVER NEXT-GEN ARRAYS FOR BETTER HEALTH AND SAFETY.
Why It Matters »

Powerful Pandemic response
PathogenDx Microarray technology delivers industry-leading sensitivity and specificity for SARS-CoV-2 (COVID-19) virus testing AND a rapid test to detect variants in a fraction of the time and cost of next-gen sequencing.

AOAC-Certified Food Certainty
PathogenDx EnviroX-F tests for Salmonella and Listeria in the same test, with the flexibility to speciate for L. mono as well. We’re bringing environmental monitoring to Food processing with same-day results without the need for enrichment.

Game-changing Molecular-level Insight
PathogenDx’s NextGen Microarray has transformed singleplex microbe testing, enabling lab technicians to rapidly interrogate dozens of microbial threats in a single test with single gene sensitivity. The applications for this advance span the diagnostic horizon.

Safer Water for All
Water isn’t a resource, it’s a basic human right. That’s why the ease, adaptability and economies delivered by PathogenDx matter in helping to address global challenges, such as safe drinking water.

Site-of-Care Safety
Today, PathogenDx innovation is applied in the testing lab. But we’re innovating ways to test for threats right in hospitals or urgent care facilities—with dramatically improved (and potentially life-saving) time-to-results.

Help for Healthcare
Detection of specific pathogens that cause urinary tract infections can enable faster, more effective treatment. The PathogenDx Microarray is being adapted to support rapid, cost-effective, quality healthcare.

The Standard in Cannabis Testing
Since 2017, PathogenDx has delivered game-changing innovation in Cannabis testing, delivering results in 6 hours or less with no need for enrichment. Over 100 labs rely upon our assays to dramatically improve time-to-result and lab efficiencies.

Innovation for What Matters
In a world where we are continuously bombarded with pathogens, PathogenDx has changed the landscape of ‘one at time’ petri dish testing or single qPCR testing. We lead the way in True Multiplex testing in a fraction of the time, cost, and effort of all other technologies.

Preventive Enviromental Monitoring (PEM)
Safety begins at the source. In addition to supporting lab testing, we’re a leader in sampling physical spaces via swabs and air testing to identify harmful pathogens and drive effective remediation.
State-Of-Art Performance
DNA and RNA-based pathogen testing kits from PathogenDx are light years ahead of other microbial testing methods. In addition to being able to test for dozens of different microbials simultaneously, testing kits from PathogenDx provide:
Ultra-Rapid
The PathogenDx Microarray platform enables high-specificity detection of a broad range microbial threats, in a single test, in less than 6 hours from new sample to result.
Scalable. Unbeatable.
Forget the one and done. The PathogenDx Microarray iinterrogates dozens of threats in a single test—with rapid adaptability—helping labs drive unprecedented throughput.
Automated Prep
Our latest innovation, Octa AutoPrep Station, delivers “set it and forget it” ease for sample prep, reducing hands-on steps, time to results and the potential for human error.
Lowest Cost
Given the dramatic efficiencies of our platform, and the addition of new automated sample prep, PathogenDx is driving down the cost of every single test and every lab process.
Maximum Detection
If it’s there, we’ll identify it, with detection and quantification down to 1CFU/gram for pathogenic organisms.
Consumables Down, ROI Up
Unlike other technologies, we’ve simplified sample prep. One sample prep for all assays, reducing the cost and environmental waste of consumables.
WE ARE A TEAM OF PASSIONATE MOLECULAR SCIENTISTS COLLABORATING TO DESIGN TESTING SYSTEMS BASED ON OUR WORLD-CLASS MICROARRAY TECHNOLOGY.
WE DELIVER MOLECULAR ASSAYS THAT INTERROGATE MULTIPLE TARGETS IN THE SAME REACTION ACROSS SAMPLE TYPES
OUR ASSAYS DELIVER SINGLE GENE COPY SENSITIVITY, AND SINGLE NUCLEOTIDE RESOLUTIONS.
How the multiplex works
Zooming graphic of the technology inside the PathogenDx Microarray.
A sample goes through hybridization inside a PathogenDX Microarray.
The sample is scanned, illuminating the florescent dye.
Safer Every Day: Updates
  • Introducing D3 Array™-UTI to the Executive War College

    Today, a wide range of urinary tract conditions are considered either complex or recurrent, creating the need for more complete and rapid insight.

    Introducing PathogenDx D3 Array™-UTI to Executive War College. This is a fast multiplexed testing solution for urinary pathogen detection run simultaneously with antibiotic resistance gene markers. This novel highly multiplexed UTI assay provides a scalable, low cost solution in a single test with results in under 6.5 hours.

    Test for 26 causative pathogens + 12 Antibiotic Resistance Genes in a single test, with qualitative detection and quantification in the same sample reaction. This multiplexed assay delivers unrivaled insight in a single test, with same-shift results.

    Learn more at https://pathogendx.com/uti/

    More »
  • DOWNLOAD WHITEPAPER – A New & Novel Approach: UTI Detection + Antibiotic Resistance in a Rapid Affordable Test

    Treatment of Urinary Tract Infections is time-consuming, taking anywhere from 2-5 days if antibiotic resistance genes are also tested. When misdiagnosed and further treatment becomes necessary, costs become unmanageable. PathogenDx D3 Array™-UTI is a fast multiplexed platform for urinary pathogen detection run simultaneously with Antibiotic Resistance genes to support clinicians in delivering rapid UTI treatment and management. This test provides:

    ▪ More flexible, faster and lower cost test than qPCR or NGS technology

    ▪ Testing for all targets of interest

    ▪ Each sample analyzed in triplicate for Quality Assurance

    ▪ 3D cross-linked array architecture enabling rapid binding

    ▪ Based on our patented technology

    Read the more thorough technical breakdown in the whitepaper from Clinical Advisor Dr. Sue Evans here.

    More »
Visit The Blog »
The future of safe
Learn more about PathogenDx and the Future of Safe: